US 8822469
Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8822469 (Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P35/00, A61P43/00